Two different groups reported a higher amount of UCA1, a lncRNA previously involved in cisplatin resistance, in Paclitaxel resistant cells, suggesting that this lncRNA may have a central role in drug resistance in ovarian cancer [91,92,97,98]. This evidence concerns the gene UCA1 and ovarian carcinoma.